Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Bipolar Disorder is a type of affective disorder in which the patient has both manic or mild manic episodes and depressive episodes.Bipolar Disorder Therapeutic refers to treatments for this psychological disorder.
The global Bipolar Disorder Therapeutic market will reach $5.2 billion by 2026. North America accounted for the largest market share due to the rising prevalence of bipolar disorder in North America. This can be attributed to high stress levels, sleep deprivation and the trend of substance abuse among the population. Moreover, government initiatives aimed at raising awareness and supporting people with bipolar disorder are also expected to drive the market growth in the region. For instance, the Center for Mental Health Services (CMHS) of the Substance Abuse and Mental Health Services Administration (SAMHSA) under the U.S. Department of Health and Human Services expanded its support for mental health treatment and recovery in 2016. The Asia-Pacific region is expected to grow at a higher rate, which can be attributed to the high prevalence of mental illness in the region. According to data released by the World Health Organization, India and China are among the countries most affected by mental disorders such as anxiety disorders, schizophrenia, and bipolar disorder. Some governments are allocating funds for bipolar research and conducting awareness campaigns to remove the stigma associated with bipolar disorder and increase treatment and compliance rates among the general population. Scientific and medical institutions are also playing an active role by conducting research and developing new drugs and therapies for bipolar disorder.
Rising prevalence of bipolar disorder due to competitive social pressures, surge in work-life stress among the urban living population, government support for causing awareness about bipolar disorder, and technological advancements that help in accurate detection of emotional and mental state of patients are some of the key factors driving the growth of the Bipolar Disorder Therapeutic market.
The report details the trend, potential and market size of Bipolar Disorder Therapeutic market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Bipolar Disorder Therapeuticmarket, defines the market attractiveness level of Bipolar Disorder Therapeutic market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Bipolar Disorder Therapeutic industry, describes the types of Bipolar Disorder Therapeutic market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bipolar Disorder Therapeutic market and the development prospects and opportunities of Bipolar Disorder Therapeutic industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bipolar Disorder Therapeutic market in Chapter 13.
By Player:
Astellas Pharma
GlaxoSmithKline
Bristol-Myers Squibb
Janssen Pharmaceuticals
Allergan
AstraZeneca
Eli Lilly
By Type:
Antipsychotics
Anticonvulsants
Mood Stabilizers
By End-User:
medical treatment
psychological counselling
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Bipolar Disorder Therapeutic Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Bipolar Disorder Therapeutic Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Bipolar Disorder Therapeutic Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Bipolar Disorder Therapeutic Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Bipolar Disorder Therapeutic Market Analysis and Outlook to 2022
-
7.1 Global Bipolar Disorder Therapeutic Consumption (2017-2022)
-
7.2 United States Bipolar Disorder Therapeutic Consumption (2017-2022)
-
7.3 Europe Bipolar Disorder Therapeutic Consumption (2017-2022)
-
7.4 China Bipolar Disorder Therapeutic Consumption (2017-2022)
-
7.5 Japan Bipolar Disorder Therapeutic Consumption (2017-2022)
-
7.6 India Bipolar Disorder Therapeutic Consumption (2017-2022)
-
7.7 South Korea Bipolar Disorder Therapeutic Consumption (2017-2022)
8 Region and Country-wise Bipolar Disorder Therapeutic Market Analysis and Outlook to 2028
-
8.1 Global Bipolar Disorder Therapeutic Consumption Forecast (2022-2028)
-
8.2 United States Bipolar Disorder Therapeutic Consumption Forecast (2022-2028)
-
8.3 Europe Bipolar Disorder Therapeutic Consumption Forecast (2022-2028)
-
8.4 China Bipolar Disorder Therapeutic Consumption Forecast (2022-2028)
-
8.5 Japan Bipolar Disorder Therapeutic Consumption Forecast (2022-2028)
-
8.6 India Bipolar Disorder Therapeutic Consumption Forecast (2022-2028)
-
8.7 South Korea Bipolar Disorder Therapeutic Consumption Forecast (2022-2028)
9 Global Bipolar Disorder Therapeutic Market Outlook by Types and Applications to 2022
-
9.1 Global Bipolar Disorder Therapeutic Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antipsychotics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Anticonvulsants Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Mood Stabilizers Consumption and Growth Rate (2017-2022)
-
9.2 Global Bipolar Disorder Therapeutic Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global medical treatment Consumption and Growth Rate (2017-2022)
-
9.2.2 Global psychological counselling Consumption and Growth Rate (2017-2022)
10 Global Bipolar Disorder Therapeutic Market Outlook by Types and Applications to 2028
-
10.1 Global Bipolar Disorder Therapeutic Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antipsychotics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Anticonvulsants Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Mood Stabilizers Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Bipolar Disorder Therapeutic Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global medical treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global psychological counselling Consumption Forecast and Growth Rate (2022-2028)
11 Global Bipolar Disorder Therapeutic Import and Export Analysis (Top 5 Countries)
-
11.1 Global Bipolar Disorder Therapeutic Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Bipolar Disorder Therapeutic Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Bipolar Disorder Therapeutic Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Bipolar Disorder Therapeutic Market Competitive Analysis
-
14.1 Astellas Pharma
-
14.1.1 Astellas Pharma Company Details
-
14.1.2 Astellas Pharma Bipolar Disorder Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Astellas Pharma Bipolar Disorder Therapeutic Product and Service
-
14.2 GlaxoSmithKline
-
14.2.1 GlaxoSmithKline Company Details
-
14.2.2 GlaxoSmithKline Bipolar Disorder Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline Bipolar Disorder Therapeutic Product and Service
-
14.3 Bristol-Myers Squibb
-
14.3.1 Bristol-Myers Squibb Company Details
-
14.3.2 Bristol-Myers Squibb Bipolar Disorder Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Bipolar Disorder Therapeutic Product and Service
-
14.4 Janssen Pharmaceuticals
-
14.4.1 Janssen Pharmaceuticals Company Details
-
14.4.2 Janssen Pharmaceuticals Bipolar Disorder Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Janssen Pharmaceuticals Bipolar Disorder Therapeutic Product and Service
-
14.5 Allergan
-
14.5.1 Allergan Company Details
-
14.5.2 Allergan Bipolar Disorder Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Allergan Bipolar Disorder Therapeutic Product and Service
-
14.6 AstraZeneca
-
14.6.1 AstraZeneca Company Details
-
14.6.2 AstraZeneca Bipolar Disorder Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AstraZeneca Bipolar Disorder Therapeutic Product and Service
-
14.7 Eli Lilly
-
14.7.1 Eli Lilly Company Details
-
14.7.2 Eli Lilly Bipolar Disorder Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Eli Lilly Bipolar Disorder Therapeutic Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Bipolar Disorder Therapeutic
-
Figure Bipolar Disorder Therapeutic Picture
-
Table Global Bipolar Disorder Therapeutic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bipolar Disorder Therapeutic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bipolar Disorder Therapeutic Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Bipolar Disorder Therapeutic Consumption by Country (2017-2022)
-
Figure United States Bipolar Disorder Therapeutic Consumption and Growth Rate (2017-2022)
-
Table Europe Bipolar Disorder Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure China Bipolar Disorder Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Japan Bipolar Disorder Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure India Bipolar Disorder Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure South Korea Bipolar Disorder Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Global Bipolar Disorder Therapeutic Consumption Forecast by Country (2022-2028)
-
Figure United States Bipolar Disorder Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Bipolar Disorder Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Bipolar Disorder Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Bipolar Disorder Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Bipolar Disorder Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Bipolar Disorder Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antipsychotics Consumption and Growth Rate (2017-2022)
-
Figure Global Anticonvulsants Consumption and Growth Rate (2017-2022)
-
Figure Global Mood Stabilizers Consumption and Growth Rate (2017-2022)
-
Figure Global medical treatment Consumption and Growth Rate (2017-2022)
-
Figure Global psychological counselling Consumption and Growth Rate (2017-2022)
-
Figure Global Antipsychotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anticonvulsants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mood Stabilizers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global medical treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global psychological counselling Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Bipolar Disorder Therapeutic Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Bipolar Disorder Therapeutic Export by Region (Top 5 Countries) (2017-2028)
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Bipolar Disorder Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Bipolar Disorder Therapeutic Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Bipolar Disorder Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Bipolar Disorder Therapeutic Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Bipolar Disorder Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Bipolar Disorder Therapeutic Product and Service
-
Table Janssen Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Janssen Pharmaceuticals Bipolar Disorder Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Pharmaceuticals Bipolar Disorder Therapeutic Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Bipolar Disorder Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Bipolar Disorder Therapeutic Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Bipolar Disorder Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Bipolar Disorder Therapeutic Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Bipolar Disorder Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Bipolar Disorder Therapeutic Product and Service
-
